跳至主要内容
临床试验/NCT04583202
NCT04583202已完成不适用

Evaluation of the Nasal and Conjunctival Response in Subjects Allergic to Birch Pollen in the ALYATEC Environmental Exposure Chamber

Alyatec2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2020年2月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Alyatec
入组人数
30
试验地点
2
主要终点
Total Nasal Symptom Score

研究概览

简要总结

The aim of this study is to assess the nasal and conjunctival response in subjects allergic to birch pollen during controlled exposures in the ALYATEC environmental exposure chamber (EEC)

详细描述

This is a single-center, single-blind, placebo-controlled study. The first part of the study consists of 6 exposure sessions in Alyatec EEC, including placebo and birch pollen allergen exposures.

The second part of the study involves in-field evaluations of rhinitis and conjunctivitis symptoms during birch pollen season.

Alyatec environmental exposure chamber, also called allergen challenge chamber, allows to evaluate allergic symptoms in standardized and reproducible conditions. All the metrological parameters (temperature, air flow, hygrometry ...) are controlled as well as the allergen concentration diffused in the room.

This enables to induce and observe rhinitis, conjunctivitis and asthma symptoms for up to 20 patients at the same time, in a reproducible way and without the potential perturbations or contaminations of the natural environment.

The current study aims to get specific information about allergic symptoms induced in the Alyatec EEC chamber in patients sensitized to birch pollen allergen.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • A clinical history of allergic rhinitis to birch pollen for at least 2 consecutive pollen seasons requiring the taking of a symptomatic drug with or without associated asthma
  • Positive skin prick tests for birch pollen (> 3 mm)
  • IgE specific to birch > 0.75 kUI / L.
  • Positive unit rapid nasal provocation test for birch pollen
  • Subjects having signed informed consent
  • Subjects affiliated to a social security scheme
  • Subjects able to understand and complete the procedures related to the study
  • Women of childbearing potential should have a negative pregnancy test throughout the study period with effective contraception

排除标准

  • Specific immunotherapy (SIT) for birch allergens for more than a month in the 3 years preceding the screening
  • Current use of Specific immunotherapy for another allergen
  • Medical history of anaphylaxis following exposure to birch pollen
  • Medical history of anaphylaxis linked to another allergen in the last 6 weeks
  • Nasal polyps, nasal septum deviation or diagnosis of non-allergic rhinitis
  • Subjects allergic to indoor environmental allergens (cat allergens, mold, dust mites) with - Obvious exposure to these allergens.
  • Uncontrolled allergic pathology (rhinitis, conjunctivitis)
  • Forced expiratory volume in 1 second (FEV1) <70% of predicted normal values
  • Moderate to severe asthma (GINA 3 to 5)

结局指标

主要结局

Total Nasal Symptom Score

时间窗: 4 hours exposure

To assess the nasal response during exposure to birch allergens compared to placebo in the ALYATEC EEC.

次要结局

  • Visual Analogue Scale for conjunctivitis(4 hours exposure)
  • Total Ocular Symptom Score(4 hours exposure)
  • Visual Analogue Scale for rhinitis(4 hours exposure)
  • Total Nasal Symptom Score(4 hours exposure)
  • Peak Nasal Inspiratory Flow(4 hours exposure)

研究者

发起方
Alyatec
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Evaluation of the Nasal and Conjunctival Response in... | 临床试验